Arnaud Bastien

Program Development Lead- CV Eliquis

Arnaud Bastien, MD is Vice President, Global Program Lead for Mavacamten and the Global Drug Development Cardiovascular Products Transition Lead at Bristol Myers Squibb.

Dr Bastien is a board-certified internist with 15+ years of industry experience. Dr Bastien has held key leadership positions in clinical drug development positions of multiple compounds at Roivant Sciences, Akros Pharma, Amarin and BMS in Cardiovascular, Metabolic and Immunology.

Dr Bastien received degrees from Columbia University, Universidad Mundial Dominicana, Dominican Republic and completed his post-graduate training in Internal Medicine at UMDNJ-Robert Wood Johnson School of Medicine, Cooper University Hospital. He also attended Rutgers University School of Business and Management for executive education in Biopharma Innovation. For the past 12 years, Dr Bastien has served as a member of the Board of Trustees at the Coriell Institute for Medical Research.

Talks About
#ClinicalDevelopment #DrugDevelopment #TranslationalMedicine

Preferred Locations
#NorthAmerica